Apellis Pharmaceuticals
APLS
APLS
300 hedge funds and large institutions have $6.65B invested in Apellis Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 105 increasing their positions, 90 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
300
Holders Change
+19
Holders Change %
+6.76%
% of All Funds
4.35%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.12%
New
66
Increased
105
Reduced
90
Closed
45
Calls
$111M
Puts
$94.7M
Net Calls
+$16.2M
Net Calls Change
-$230M
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$58.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$69.7M |
| 3 |
Millennium Management
New York
|
$46.2M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$94.7M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
$32.3M |
